The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Abstract
Development of resistance to chemotherapy in cancer continues to be a major challenge in cancer management. Ferroptosis, a unique type of cell death, is mechanistically and morphologically different from other forms of cell death. Ferroptosis plays a pivotal role in inhibiting tumour growth and has presented new opportunities for treatment of chemotherapy-insensitive tumours in recent years. Emerging studies have suggested that ferroptosis can regulate the therapeutic responses of tumours. Accumulating evidence supports ferroptosis as a potential target for chemotherapy resistance. Pharmacological induction of ferroptosis could reverse drug resistance in tumours. In this review article, we first discuss the key principles of chemotherapeutic resistance in cancer. We then provide a brief overview of the core mechanisms of ferroptosis in cancer chemotherapeutic drug resistance. Finally, we summarise the emerging data that supports the fact that chemotherapy resistance in different types of cancers could be subdued by pharmacologically inducing ferroptosis. This review article suggests that pharmacological induction of ferroptosis by bioactive compounds (ferroptosis inducers) could overcome chemotherapeutic drug resistance. This article also highlights some promising therapeutic avenues that could be used to overcome chemotherapeutic drug resistance in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–207 of 207
The role of non-apoptotic cell death in the treatment and drug-resistance of digestive tumors
Yang, Y., Bai, L., Liao, W., Feng, M., Zhang, M., Wu, Q., Zhou, K., Wen, F., Lei, W., Zhang, N., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112678 · Cited by 19
Song, L., Wu, J., Fu, H., Wu, C., Tong, X., & Zhang, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.921963 · Cited by 19
Mechanisms of Ferroptosis and Application to Head and Neck Squamous Cell Carcinoma Treatments
Li, S., Liu, Y., Li, J., Zhao, X. B., & Yu, D. (2021) · DNA and Cell Biology · doi:10.1089/dna.2021.0023 · Cited by 18
Pharmacological targets for the induction of ferroptosis: Focus on Neuroblastoma and Glioblastoma
Ferrada, L., Barahona, M. J., Salazar, K., Godoy, A., Vera, M., & Nualart, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858480 · Cited by 16
The Role of Ferroptosis Signature in Overall Survival and Chemotherapy of Pancreatic Adenocarcinoma
Wei, W., Hu, Q., Li, W., Li, M., Dong, S., Peng, Y., Yin, J., Lu, Y., Liu, L., & Zhao, Q. (2021) · DNA and Cell Biology · doi:10.1089/dna.2021.0594 · Cited by 14
Wei, Y., Duan, S., Gong, F., & Li, Q. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.02.103 · Cited by 14
Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer
Shao, Y., Li, H., Du, R., Meng, J., & Yang, G. S. (2018) · Journal of Cancer · doi:10.7150/jca.24550 · Cited by 11
Cited by
Polyunsaturated Fatty Acids Drive Lipid Peroxidation during Ferroptosis
Mortensen, M. S., Ruiz, J., & Watts, J. L. (2023) · Cells · doi:10.3390/cells12050804 · Cited by 312
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Wang, Y., Chen, Y., Zhang, J., Yang, Y., Fleishman, J. S., Wang, Y., Wang, J., Chen, J., Li, Y., & Wang, H. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101018 · Cited by 256
Self-citationThe role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics
Tang, J., Chen, Y., Wang, C., Xia, Y., Yu, T., Tang, M., Meng, K., Yin, L., Yang, Y., Shen, L., et al. (2024) · MedComm · doi:10.1002/mco2.663 · Cited by 31
Metadata
- Authors
- Wang, Y., Wu, X., Ren, Z., Li, Y., Zou, W., Chen, J., & Wang, H.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 66
- Pages
- 100916
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W4313560081
- Cited by
- 361
- References
- 207
- FWCI
- 39.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.